|
Market Closed -
Other stock markets
|
After hours 03:59:59 pm | |||
| 42.95 EUR | +3.74% |
|
42.98 | +0.06% |
| Nov. 06 | Equasens surges after 9m trading update |  |
| Nov. 05 | Equasens Q3 revenue eur 172.2 million | RE |
| Capitalization | 622M 726M 582M 544M 1.01B 65.19B 1.1B 6.83B 2.63B 30.8B 2.72B 2.67B 112B | P/E ratio 2025 * |
16.4x | P/E ratio 2026 * | 14.1x |
|---|---|---|---|---|---|
| Enterprise value | 538M 628M 503M 470M 875M 56.38B 948M 5.9B 2.28B 26.64B 2.36B 2.31B 97.13B | EV / Sales 2025 * |
2.28x | EV / Sales 2026 * | 2.02x |
| Free-Float |
32.21% | Yield 2025 * |
3.36% | Yield 2026 * | 3.65% |
| Nov. 05 | Equasens: Q3 2025 revenue | GL |
| Sep. 26 | Equasens: 2025 half-year results | GL |
| Sep. 26 | Equasens: 2025 half-year results | AQ |
| Jul. 31 | Equasens: H1 revenue at 30 June 2025: €116.0m | GL |
| Jul. 03 | Equasens: Appointment at the head of the Pharmagest Division | GL |
| 1 day | +3.74% | ||
| 1 week | +2.26% | ||
| 1 month | +14.53% | ||
| 3 months | -1.72% | ||
| 6 months | -16.60% | ||
| Current year | -2.94% |
| 1 week | 41.1 |  | 43.3 |
| 1 month | 36.25 | | 43.3 |
| Current year | 30.55 | | 53.7 |
| 1 year | 30.55 | | 53.7 |
| 3 years | 30.55 | | 85.8 |
| 5 years | 30.55 | | 124.2 |
| 10 years | 19.84 | | 124.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2022-04-21 | |
| Director of Finance/CFO | - | 2022-12-31 | |
Damien Maringer
CTO | Chief Tech/Sci/R&D Officer | - | 2018-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Chapusot
CHM | Chairman | 66 | 2009-12-31 |
| Director/Board Member | 60 | 2008-12-31 | |
Daniel Antoine
BRD | Director/Board Member | 73 | 2001-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +19.15% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.74% | +2.26% | +6.71% | -43.56% | 726M | |
| +1.77% | -0.19% | +31.91% | +108.93% | 283B | |
| -1.29% | +7.74% | -25.19% | -7.99% | 169B | |
| +1.55% | +2.10% | -24.95% | -6.10% | 128B | |
| -0.32% | +1.61% | -14.53% | -1.89% | 105B | |
| -11.41% | -6.56% | +25.88% | +73.10% | 89.77B | |
| +0.73% | +0.23% | -19.02% | +29.87% | 73.1B | |
| +1.20% | +2.55% | -15.56% | -2.46% | 72.58B | |
| -0.59% | -4.69% | +116.11% | +492.86% | 49.54B | |
| +0.86% | +2.27% | -12.49% | +45.71% | 49.23B | |
| Average | -0.52% | +1.60% | +6.89% | +68.85% | 101.99B | |
| Weighted average by Cap. | -0.65% | +2.43% | +4.90% | +62.45% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 236M 275M 221M 206M 384M 24.71B 416M 2.59B 999M 11.68B 1.03B 1.01B 42.57B | 253M 295M 237M 221M 412M 26.52B 446M 2.78B 1.07B 12.53B 1.11B 1.08B 45.69B |
| Net income | 38.21M 44.55M 35.73M 33.37M 62.13M 4B 67.3M 419M 162M 1.89B 167M 164M 6.9B | 44.24M 51.59M 41.37M 38.64M 71.94M 4.63B 77.93M 485M 187M 2.19B 194M 189M 7.98B |
| Net Debt | -84.09M -98.06M -78.64M -73.44M -137M -8.81B -148M -923M -356M -4.16B -368M -360M -15.18B | -110M -129M -103M -96.48M -180M -11.57B -195M -1.21B -468M -5.47B -483M -473M -19.94B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-04 | 42.95 € | +3.74% | 6,021 |
| 25-12-03 | 41.40 € | -0.84% | 6,605 |
| 25-12-02 | 41.75 € | -0.36% | 5,206 |
| 25-12-01 | 41.90 € | -2.44% | 7,118 |
| 25-11-28 | 42.95 € | +0.12% | 3,771 |
Real-time Euronext Paris, December 04, 2025 at 11:55 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EQS Stock
Select your edition
All financial news and data tailored to specific country editions
